These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1591362)

  • 1. Cyst decompression surgery for autosomal dominant polycystic kidney disease.
    Elzinga LW; Barry JM; Torres VE; Zincke H; Wahner HW; Swan S; Bennett WM
    J Am Soc Nephrol; 1992 Jan; 2(7):1219-26. PubMed ID: 1591362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic cyst decortication in autosomal dominant polycystic kidney disease: impact on pain, hypertension, and renal function.
    Lee DI; Andreoni CR; Rehman J; Landman J; Ragab M; Yan Y; Chen C; Shindel A; Middleton W; Shalhav A; McDougall EM; Clayman RV
    J Endourol; 2003 Aug; 17(6):345-54. PubMed ID: 12965058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term impact of laparoscopic cyst decortication on renal function, hypertension and pain control in patients with autosomal dominant polycystic kidney disease.
    Haseebuddin M; Tanagho YS; Millar M; Roytman T; Chen C; Clayman RV; Miller B; Desai A; Benway B; Bhayani S; Figenshau RS
    J Urol; 2012 Oct; 188(4):1239-44. PubMed ID: 22902029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical cyst decortication in autosomal dominant polycystic kidney disease.
    Millar M; Tanagho YS; Haseebuddin M; Clayman RV; Bhayani SB; Figenshau RS
    J Endourol; 2013 May; 27(5):528-34. PubMed ID: 23157176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
    Spithoven EM; Meijer E; Boertien WE; Sinkeler SJ; Tent H; de Jong PE; Navis G; Gansevoort RT
    Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of uninephrectomy on progression of renal failure in autosomal dominant polycystic kidney disease.
    Zeier M; Geberth S; Gonzalo A; Chauveau D; Grünfeld JP; Ritz E
    J Am Soc Nephrol; 1992 Nov; 3(5):1119-23. PubMed ID: 1482752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should kidney volume be used as an indicator of surgical occasion for patients with autosomal dominant polycystic kidney disease?
    Yu J; Li B; Xiang YZ; Qi TG; Jin XB; Xiong H
    Medicine (Baltimore); 2018 Jul; 97(27):e11445. PubMed ID: 29979446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.
    Klahr S; Breyer JA; Beck GJ; Dennis VW; Hartman JA; Roth D; Steinman TI; Wang SR; Yamamoto ME
    J Am Soc Nephrol; 1995 Jun; 5(12):2037-47. PubMed ID: 7579052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.
    Choukroun G; Itakura Y; Albouze G; Christophe JL; Man NK; Grünfeld JP; Jungers P
    J Am Soc Nephrol; 1995 Dec; 6(6):1634-42. PubMed ID: 8749691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD).
    Wong ATY; Mannix C; Grantham JJ; Allman-Farinelli M; Badve SV; Boudville N; Byth K; Chan J; Coulshed S; Edwards ME; Erickson BJ; Fernando M; Foster S; Haloob I; Harris DCH; Hawley CM; Hill J; Howard K; Howell M; Jiang SH; Johnson DW; Kline TL; Kumar K; Lee VW; Lonergan M; Mai J; McCloud P; Peduto A; Rangan A; Roger SD; Sud K; Torres V; Vilayur E; Rangan GK
    BMJ Open; 2018 Jan; 8(1):e018794. PubMed ID: 29358433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic nephrectomy in patients with end-stage renal disease and autosomal dominant polycystic kidney disease.
    Dunn MD; Portis AJ; Elbahnasy AM; Shalhav AL; Rothstein M; McDougall EM; Clayman RV
    Am J Kidney Dis; 2000 Apr; 35(4):720-5. PubMed ID: 10739795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
    Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
    Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
    Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
    J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort.
    Rule AD; Torres VE; Chapman AB; Grantham JJ; Guay-Woodford LM; Bae KT; Klahr S; Bennett WM; Meyers CM; Thompson PA; Miller JP;
    J Am Soc Nephrol; 2006 Mar; 17(3):854-62. PubMed ID: 16452494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease.
    King BF; Reed JE; Bergstralh EJ; Sheedy PF; Torres VE
    J Am Soc Nephrol; 2000 Aug; 11(8):1505-1511. PubMed ID: 10906164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with autosomal dominant polycystic kidney disease in patients before and after renal transplantation: a 7-year observation.
    Sulikowski T; Tejchman K; Zietek Z; Rózański J; Domański L; Kamiński M; Sieńko J; Romanowski M; Nowacki M; Pabisiak K; Kaczmarczyk M; Ciechanowski K; Ciechanowicz A; Ostrowski M
    Transplant Proc; 2009; 41(1):177-80. PubMed ID: 19249508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic kidney disease with renal calculi treated by percutaneous nephrolithotomy: a report of 11 cases.
    Zhang J; Zhang J; Xing N
    Urol Int; 2014; 92(4):427-32. PubMed ID: 24481047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: HOW AND WHY SHOULD WE IDENTIFY THE PATIENTS "RAPIDLY PROGRESSING" TO END-STAGE RENAL DISEASE?].
    Bodson A; Meunier P; Krzesinski JM; Jouret F
    Rev Med Liege; 2016 Apr; 71(4):184-92. PubMed ID: 27295898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
    Coban M; Inci A
    Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.